Article
Chemistry, Medicinal
Xiaolin Li, Tianrong Xun, Huayan Xu, Xiaoyan Pang, Bin Yang, Junfeng Wang, Xuefeng Zhou, Xiuping Lin, Suiyi Tan, Yonghong Liu, Shengrong Liao
Summary: Fourteen novel 3,6-diunsaturated 2,5-diketopiperazine derivatives, along with two known ones, were designed and synthesized based on marine natural products. These derivatives showed moderate to good anticancer capacities against A549 and Hela cancer cells. Compound 11 exhibited strong inhibitory activities and could induce apoptosis and block cell cycle progression in both cell lines.
Review
Chemistry, Medicinal
Yehezkiel Steven Kurniawan, Krisfian Tata Aneka Priyangga, Jumina, Harno Dwi Pranowo, Eti Nurwening Sholikhah, Abdul Karim Zulkarnain, Hana Anisa Fatimi, Jeffry Julianus
Summary: Xanthone, a heterocyclic compound with unique structure, has shown anticancer activity against various cancer cell lines.
Article
Biochemistry & Molecular Biology
Ashish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, Akash Verma, Naveen Kumar, Jyoti Parkash, Vinod Kumar
Summary: A series of morpholine substituted quinazoline derivatives have been synthesized and evaluated for their cytotoxic potential against several cancer cell lines. Among them, AK-3 and AK-10 showed significant cytotoxic activity against three different cell lines and were found to inhibit cell proliferation in the G1 phase of the cell cycle through apoptosis.
RSC MEDICINAL CHEMISTRY
(2022)
Article
Biochemistry & Molecular Biology
Malgorzata Jelen, Krystian Pluta, Malgorzata Szmielew, Beata Morak-Mlodawska, Kinga Herman, Klaudia Giercuszkiewicz, Anna Kasprzycka, Magdalena Skonieczna
Summary: A series of novel double-angularly condensed diquinothiazines with aminoalkyl and phenyl groups showed excellent broad-spectrum anticancer activity.
Article
Chemistry, Medicinal
Wei Han, Jieyi Li, Qianqian Li, Yusang Yang, Jiabin Li, Xiaowen Xue
Summary: Two novel series of derivatives were synthesized and evaluated for their cytotoxic activity against colon cancer and breast cancer cells. Most compounds exhibited better inhibitory activity than the reference compound, and HCT-116 cells were more sensitive to the compounds.
Article
Biochemistry & Molecular Biology
Thidarath Rattanaburee, Patpanat Sermmai, Kornthip Tangthana-umrung, Tienthong Thongpanchang, Potchanapond Graidist
Summary: This study investigated the cytotoxicity and anticancer activity of (+/-)-kusunokinin derivatives on various cancer cells. The results showed that (+/-)-TTPG-B exhibited the strongest cytotoxicity on breast cancer and cholangiocarcinoma cells. Both (+/-)-TTPG-A and (+/-)-TTPG-B induced cell cycle arrest and apoptosis, and their effects were superior to (+/-)-kusunokinin.
Article
Cell Biology
Ibrahim Morgan, Ludger A. Wessjohann, Goran N. Kaluderovic
Summary: Anthraquinone derivatives are a class of compounds that exhibit various biological activities, including antifungal, antibacterial, antiviral, and anticancer activities. This study tested various synthetic anthraquinone derivatives against different cancer cell lines and found that most of them exhibit anticancer effects. One specific compound, 1,4-bis(benzyloxy)-2,3-bis(hydroxymethyl)anthracene-9,10-dione, exhibited the highest cytotoxicity against PC3 cells and was further investigated for its mechanism of action. The compound was found to induce apoptosis, disrupt cellular equilibrium, and cause cell cycle arrest.
Article
Chemistry, Medicinal
Lan Luo, Jing Jing Jia, Qiu Zhong, Xue Zhong, Shilong Zheng, Guangdi Wang, Ling He
Summary: The newly synthesized compound 6a has shown promising anticancer activity by inhibiting cell growth and inducing apoptosis in vitro, as well as suppressing tumor growth in vivo, indicating its potential as a future anticancer agent.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Pratibha Kurkute, Amol Jadhav, Sangeeta V. Pandit
Summary: Lung cancer is a highly prevalent disease and the leading cause of death after breast cancer. Current therapies for lung cancer have limitations, and there is a need to explore alternative therapeutic agents. In this study, a snake venom peptide called NN-32 showed cytotoxic effects on lung cancer cells, indicating its potential as an anti-cancer agent.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
(2023)
Article
Public, Environmental & Occupational Health
Zafer Hasan Ali Sak, Faruk Suzergoz, Veli Tarik Kasumov, Ali Osman Gurol
Summary: This study tested a series of Schiff base compounds for their anticancer properties on the A549 cell line representing NSCLC, with some compounds showing high cytotoxic and antiproliferative effects, indicating their potential as chemotherapeutic agents for lung cancer. Immunofluorescence and immunohistochemical analysis confirmed that the cytotoxic effects were induced by apoptosis, providing an important advantage for further research.
IRANIAN JOURNAL OF PUBLIC HEALTH
(2021)
Article
Polymer Science
Shadab Md, Samaa T. Abdullah, Nabil A. Alhakamy, Ahmad Bani-Jaber, Ammu Kutty Radhakrishnan, Shahid Karim, Naiyer Shahzad, Gamal A. Gabr, Abdulmohsin J. Alamoudi, Waleed Y. Rizg
Summary: The study developed gastro-retentive sustained-release ambroxol nanosuspensions, utilizing a complex co-precipitate formulation and demonstrating significant enhancement of anticancer effects on A549 lung cancer cells. The nanosuspensions achieved rapid floating behavior and distribution to pulmonary tissue, with increased levels of caspase-3, Bax, and p53 compared to free ambroxol. Additionally, the developed sustained-release gel showed successful gastro-retentive effects.
Article
Pharmacology & Pharmacy
Somaya A. Abdel-Rahman, Emad I. Wafa, Kareem Ebeid, Sean M. Geary, Youssef W. Naguib, Ashraf K. El-Damasy, Aliasger K. Salem
Summary: Different tetrahydrobenzo[b]thiophene derivatives, especially the benzyl urea derivative BU17, have been identified as potent antitumor compounds with broad-spectrum activity against several cancer cell lines through inhibiting tubulin polymerization. BU17 induces apoptosis, potentially by targeting WEE1 kinase and tubulin. Furthermore, BU17-loaded PLGA nanoparticles exhibit significantly enhanced antitumor activity compared to the soluble form.
ADVANCED THERAPEUTICS
(2021)
Article
Chemistry, Medicinal
David Tsuyoshi Hiramatsu Castro, Daniel Ferreira Leite, Debora da Silva Baldivia, Helder Freitas dos Santos, Sikiru Olaitan Balogun, Denise Brentan da Silva, Carlos Alexandre Carollo, Kely de Picoli Souza, Edson Lucas dos Santos
Summary: In this study, a novel compound was isolated, identified, and its chemical structure was determined from the roots of Senna velutina. The compound showed anticancer activity against melanoma and leukemic cell lines through apoptosis and other cell death pathways. These findings suggest that this compound has potential applications in cancer therapy.
Article
Biochemistry & Molecular Biology
Yara El-Dash, Emad Elzayat, Amr M. Abdou, Rasha A. Hassan
Summary: Novel hybrid compounds of hexahydrobenzo[4,5]thieno[2,3-d]pyrimidine with aminothiazole scaffolds were synthesized and evaluated for their cytotoxic activity against human tumor cell lines. Compounds 7c, 7d, and 7e showed significant antiproliferative activities, with 7c demonstrating excellent cytotoxic activity against various cancer cell lines. Compound 7c also exhibited potential as a VEGFR-2 inhibitor and induced G2/M phase cell cycle arrest and apoptosis in treated cells.
BIOORGANIC CHEMISTRY
(2021)
Article
Chemistry, Medicinal
Sougata Santra, Ainur D. Sharapov, Ramil F. Fatykhov, Anastasya P. Potapova, Igor A. Khalymbadzha, Maria I. Valieva, Dmitry S. Kopchuk, Grigory V. Zyryanov, Alexander S. Bunev, Vsevolod V. Melekhin, Vasiliy S. Gaviko, Andrey A. Zonov
Summary: In this study, 21 novel xanthone and acridone derivatives were synthesized via reactions between 1,2,4-triazine derivatives and 1-hydroxy-3-methoxy-10-methylacridone, 1,3-dimethoxy-, and 1,3-dihydroxanthone, followed by dihydrotiazine ring aromatization. The synthesized compounds were evaluated for their anticancer activity against colorectal cancer HCT116, glioblastoma A-172, breast cancer Hs578T, and human embryonic kidney HEK-293 tumor cell lines. Five compounds (7a, 7e, 9e, 14a, and 14b) showed promising in vitro antiproliferative activities against these cancer cell lines. Compounds 7a and 7e exhibited low toxicity for normal human embryonic kidney (HEK-293) cells, suggesting their potential as anticancer agents. Annexin V assay revealed that compound 7e activates apoptotic mechanisms and inhibits proliferation in glioblastoma cells.
Article
Biology
Shanmin Yang, Mei Zhang, Chun Chen, Yongbin Cao, Yeping Tian, Yangsong Guo, Bingrong Zhang, Xiaohui Wang, Liangjie Yin, Zhenhuan Zhang, Walter O'Dell, Paul Okunieff, Lurong Zhang
RADIATION RESEARCH
(2015)
Article
Oncology
Chun Chen, Shanmin Yang, Mei Zhang, Zhenhuan Zhang, Jingshen Hong, Deping Han, Jun Ma, Steven B. Zhang, Paul Okunieff, Lurong Zhang
CANCER BIOLOGY & THERAPY
(2016)
Article
Oncology
Kazuhiko Kuwahara, Mutsuko Yamamoto-Ibusuki, Zhenhuan Zhang, Suchada Phimsen, Naomi Gondo, Hiroko Yamashita, Toru Takeo, Naomi Nakagata, Daisuke Yamashita, Yoshimi Fukushima, Yutaka Yamamoto, Hiroji Iwata, Hideyuki Saya, Eisaku Kondo, Keitaro Matsuo, Motohiro Takeya, Hirotaka Iwase, Nobuo Sakaguchi
Article
Biology
Steven B. Zhang, Shanmin Yang, Zhenhuan Zhang, Amy Zhang, Mei Zhang, Liangjie Yin, Katherine Casey-Sawicki, Steven Swarts, Sadasivan Vidyasagar, Lurong Zhang, Paul Okunieff
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
(2017)
Article
Oncology
Weifeng Xu, Bing Wu, Lengxi Fu, Junying Chen, Zeng Wang, Fei Huang, Jinrong Chen, Mei Zhang, Zhenhuan Zhang, Jingan Lin, Ruilong Lan, Ruiqing Chen, Wei Chen, Long Chen, Jinsheng Hong, Weijian Zhang, Yuxiong Ding, Paul Okunieff, Jianhua Lin, Lurong Zhang
Article
Oncology
Chun Chen, Shanmin Yang, Mei Zhang, Zhenhuan Zhang, Steven B. Zhang, Bing Wu, Jinsheng Hong, Weijian Zhang, Jianhua Lin, Paul Okunieff, Lurong Zhang
Article
Environmental Sciences
Kate Casey-Sawicki, Mei Zhang, Sunghee Kim, Amy Zhang, Steven B. Zhang, Zhenhuan Zhang, Ravi Singh, Shanmin Yang, Steven Swarts, Sadasivan Vidyasagar, Lurong Zhang, Aiguo Zhang, Paul Okunieff
Article
Biochemistry & Molecular Biology
Zhenhuan Zhang, Yunguang Sun, Young-Wook Cho, Carson C. Chow, S. Stoney Simons
JOURNAL OF BIOLOGICAL CHEMISTRY
(2013)
Article
Biochemistry & Molecular Biology
Min Luo, Xinping Lu, Rong Zhu, Zhenhuan Zhang, Carson C. Chow, Rong Li, S. Stoney Simons
JOURNAL OF BIOLOGICAL CHEMISTRY
(2013)
Article
Biochemical Research Methods
Peng Shi, Jinsheng Hong, Yue Huang, Zhenhuan Zhang, Mei Zhang, Lurong Zhang
JOURNAL OF BIOMEDICAL OPTICS
(2014)
Article
Oncology
Natalie A. Lockney, Mei Zhang, Christopher G. Morris, Romaine Charles Nichols, Paul Okunieff, Steven Swarts, Zhenhuan Zhang, Bingrong Zhang, Amy Zhang, Bradford S. Hoppe
Article
Medicine, Research & Experimental
Naomi Gondo, Yasuhiro Sakai, Zhenhuan Zhang, Yukari Hato, Kiyotaka Kuzushima, Suchada Phimsen, Yoshiaki Kawashima, Makoto Kuroda, Motoshi Suzuki, Seiji Okada, Hiroji Iwata, Tatsuya Toyama, Andri Rezano, Kazuhiko Kuwahara
Summary: Depletion of DSS1 and PCID2, components of the TREX-2 complex, increases chemosensitivity in breast carcinomas independent of BRCA2 mutations. Particularly, the low expression of DSS1 in normal breast tissues suggests that targeting DSS1 could be a promising approach for treating breast cancer.
LABORATORY INVESTIGATION
(2021)
Article
Oncology
Natalie A. Lockney, Randal H. Henderson, Steven G. Swarts, Zhenhuan Zhang, Bingrong Zhang, Jennifer Li, Robert A. Zlotecki, Christopher G. Morris, Katherine A. Casey-Sawicki, Paul G. Okunieff
Summary: This study found that circulating plasma cell-free DNA levels may have the potential to predict gastrointestinal toxicity in patients undergoing prostate cancer treatment. Correlations were observed between pre-RT cfDNA levels and GI toxicities, suggesting cfDNA could provide a biological estimate to complement dose-volume histograms.
INTERNATIONAL JOURNAL OF PARTICLE THERAPY
(2022)
Article
Oncology
Natalie A. Lockney, Randal Henderson, Steven G. Swarts, Zhenhuan Zhang, Bingrong Zhang, Jennifer Li, Robert A. Zlotecki, Christopher G. Morris, Katherine Casey-Sawicki, Paul Okunieff
INTERNATIONAL JOURNAL OF PARTICLE THERAPY
(2020)